A critical discovery in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This crucial tumor inhibitor protein is frequently disabled in many types of cancer, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research